Historically, natural products have been a rich source of lead molecules in drug discovery. In particular, products to treat infectious diseases have been developed and several reports about potentialities of essential oils (EO) against Leishmania could be found. In this study, we report the chemical characterization, anti-leishmanial effects and cytotoxicity of the EO from Artemisia absinthium L. Chemical analysis revealed the EO to be composed of 18 compounds, 11 of which were identified, accounting for 64.1% of the composition. The main component of the EO was trans-sabinyl acetate, which made up 36.7%. In vitro anti-leishmanial screening showed that the A. absinthium EO inhibited the growth of promastigotes (14.4 ± 3.6 μg/mL) and amastigotes (13.4 ± 2.4 μg/mL) of L. amazonensis; while cytotoxicity evaluation caused 6 fold higher values than those for the parasites. In a model of experimental cutaneous leishmaniasis in BALB/c mice, five doses of EO at 30 mg/kg by intralesional route demonstrated control of lesion size and parasite burden (p< 0.05) compared with animals treated with glucantime and untreated mice. In conclusion, in vitro and in vivo results showed the potential of EO from A. absinthium as a promising source for lead or active compounds against Leishmania, which could be explored.
(a) ButlerM.S. (2008) Natural products to drugs: natural product-derived compounds in clinical trials. Natural Product Reports, 25, 475–516;(b) Yuliana ND, Khatib A, Choi YH, Verpoorte R. (2011) Metabolomics for bioactivity assessment of natural products. Phytotherapy Research, 25, 157–169.
2.
(a) MonzoteL., AlarcónO., SetzerW. (2012) Antiprotozoal activity of essential oils: a brief review from literature. Agriculturae Conspectus Scientificus, 77, 167–175;(b) Tiuman TS, Santos AO, Ueda-Nakamura T, Filho BP, Nakamura CV. (2011) Recent advances in leishmaniasis treatment. International Journal of Infectious Diseases, 15, e525–e532; (c) Sen R, Chatterjee M. (2011) Plant derived therapeutics for the treatment of leishmaniasis. Phytomedicine, 18, 1056–1069.
3.
AlvarJ., VélezI.D., BernC., HerreroM., DesjeuxP., CanoJ., JanninJ., denBoerM. WHO Leishmaniasis Control Team. (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE, 7, e3571.
4.
BernC., MaguireJ.H., AlvarJ. (2008) Complexities of assessing the disease burden attributable to leishmaniasis. PLoS Neglected Tropical Diseases, 2, e313.
5.
(a) MurrayH.W., BermanJ.D., DaviesCr, SaraviaN.G. (2005) Advances in leishmaniasis. Lancet, 366, 1561–1577;(b) Ameen M. (2010) Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics. Clinical and Experimental Dermatology, 35, 699–705; (c) Okwor I, Mou Z, Liu D, Uzonna J. (2012) Protective immunity and vaccination against cutaneous leishmaniasis. Frontiers in Immunology, 3, 128 (13 pages).
6.
Sunset Editors. (1995) Sunset Western Garden Book.Oxmoor House, Tampa, Florida, pp. 606–607.
(a) JoshiR.K. (2013) Volatile composition and antimicrobial activity of the essential oil of Artemisia absinthium growing in Western Ghats region of North West Karnataka, India. Pharmaceutical Biology, 51, 888–892;(b) Lopes-Lutz D, Alviano DS, Alviano CS, Kolodziejczyk PP. (2008) Screening of chemical composition, antimicrobial and antioxidant activities of Artemisia essential oils. Phytochemistry, 69, 1732–1738.
10.
BoraK.S., SharmaA. (2011) Evaluation of antioxidant and free-radical scavenging potential of Artemisia absinthium. Pharmaceutical Biology, 49, 1216–1223.
11.
ShafiG., HasanT.N., SyedN.A., Al-HazzaniA.A., AlshatwiA.A., JyothiA., MunshiA. (2012) Artemisia absinthium (AA): a novel potential complementary and alternative medicine for breast cancer. Molecular Biology Reports, 39, 7373–7379.
12.
(a) IrshadS., MannanA., MirzaB. (2011) Antimalarial activity of three Pakistani medicinal plants. Pakistan Journal of Pharmaceutical Sciences, 24, 589–591;(b) Yıldız K, Başalan M, Duru O, Gökpınar S. (2011) Antiparasitic efficiency of Artemisia absinthium on Toxocaracati in naturally infected cats. Türkiye Parazitoloji Dergisi, 35, 10–44; (c) Iqbal A, Tariq KA, Wazir VS, Singh R. (2013) Antiparasitic efficacy of Artemisia absinthium, toltrazuril and amprolium against intestinal coccidiosis in goats. Journal of Parasitic Diseases, 37, 88–93; (d) Godara R, Parveen S, Katoch R, Yadav A, Verma PK, Katoch M, Kaur D, Ganai A, Raghuvanshi P, Singh NK. (2014) Acaricidal activity of extract of Artemisia absinthium against Rhipicephalus sanguineus of dogs. Parasitology Research, 113, 747–754; (e) Kifleyohannes T, Terefe G, Tolossa YH, Giday M, Kebede N. (2014) Effect of crude extracts of Moringa stenopetala and Artemisia absinthium on parasitaemia of mice infected with Trypanosoma congolense. BMC Research Notes, 7, 390.
13.
Fernández-CalienesA., MartínezJ.M., LizamaR.S., VermeerschM., CosP., MaesL. (2008) In vitro anti-microbial activity of the Cuban medicinal plants Simarouba glauca DC, Melaleuca leucadendron L and Artemisia absinthium L. Memorias do Instituto Oswaldo Cruz, 103, 615–618.
14.
MendiolaJ., BosaM., PerezN., HernandezH., TorresD. (1991) Extracts of Artemisia abrotanum and Artemisia absinthium inhibit growth of Naegleria fowleri in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene, 85, 78–79.
15.
LogartoA., SilvaR., GuerraI., IglesiasL. (2001) Comparative study of the assay of Artemia salina L. and the estimate of the medium lethal dose (LD50 value) in mice, to determine oral acute toxicity of plant extracts. Phytomedicine, 8, 395–400.
16.
ChalalaM., GarcíaD.M., CrespoM., RodríguezC.A., HechevarríaI. (2004) Evaluación y control de calidad de la tintura homeopática de Artemisia absinthium L. Revista Cubana de Plantas Medicinales, 9, 1–4.
17.
SharopovF.S., SulaimonovaV.A., SetzerW.N. (2012) Composition of the essential oil of Artemisia absinthium from Tajikistan. Records of Natural Products, 6, 127–134.
18.
ChialvaF., LiddleP.A.P., DogliaG. (1983) Chemotaxonomy of wormwood (Artemisia absinthium L.). Zeitschrift für Lebensmittel-Untersuchung und Forschung, 176, 363–366.
19.
OravA., RaalA., ArakE., MüüriseppM., KailasT. (2006) Composition of the essential oil of Artemisia absinthium L. of different geographical origin. Proceedings of the Estonian Academy of Sciences, Chemistry, 55, 155–165.
20.
RezaeinodehiA., KhangholiS. (2008) Chemical composition of the essential oil of Artemisia absinthium growing wild in Iran. Pakistan Journal of Biological Sciences, 11, 946–949.
21.
JudzentieneA., TomiF., CasanovaJ. (2009) Analysis of essential oils of Artemisia absinthium L. from Lithuania by CC, GC(RI), GC-MS and 13C NMR. Natural Product Communications, 4, 1113–1118.
22.
PinoJ.A., RosadoA., FuentesV. (1997) Chemical composition of the essential oil of Artemisia absinthium L. from Cuba. Journal of Essential Oil Research, 9, 87–89.
23.
MonzoteL., HillG.M., CuellarA., ScullR., SetzerW.N. (2012) Chemical composition and anti-proliferative properties of Bursera graveolens essential oil. Natural Product Communications, 7, 1531–1534.
24.
MonzoteL., GarcíaM., ScullR., CuellarA., SetzerW.N. (2014) Antileishmanial activity of the essential oil from Bixa orellana. Phytotherapy Research, 28, 753–758.
25.
DiasC.N., RodriguesK.A., CarvalhoF.A., CarneiroS.M., MaiaJ.G., AndradeE.H., MoraesD.F. (2013) Molluscicidal and leishmanicidal activity of the leaf essential oil of Syzygium cumini (L.) SKEELS from Brazil. Chemistry and Biodiversity, 10, 1133–1141.
26.
de MedeirosMd, da SilvaA.C., CitóA.M., BorgesA.R., de LimaS.G., LopesJ.A., FigueiredoR.C. (2011) In vitro antileishmanial activity and cytotoxicity of essential oil from Lippia sidoides Cham. Parasitology International, 60, 237–241.
27.
Ueda-NakamuraT., Mendonça-FilhoR.R., Morgado-DíazJ.A., Korehisa MazaP., Prado Dias FilhoB., Aparício Garcia CortezD., AlvianoD.S., RosaMdS, LopesA.H., AlvianoC.S., NakamuraC.V. (2006) Antileishmanial activity of eugenol-rich essential oil from Ocimum gratissimum. Parasitology International, 55, 99–105.
28.
Sobarzo-SánchezE., Bilbao-RamosP., Dea-AyuelaM., González-DíazH., YañézM., UriarteE., SantanaL., Martínez-SernándezV., Bolás-FermándezF., UbeiraF.M. (2013) Synthetic oxoisoaporphine alkaloids: In vitro, in vivo and in silico assessment of antileishmanial activities. PLoS ONE, 8, e77560.
29.
TarikuY., HymeteA., HailuA., RohloffJ. (2011) In vitro evaluation of antileishmanial activity and toxicity of essential oils of Artemisia absinthium and Echinopske bericho. Chemistry and Biodiversity, 8, 614–623.
30.
KhatamiA., TalaeeR., RahshenasM., KhamesipourA., MehryanP., TehraniS., DowlatiY., FiroozA. (2013) Dressings combined with injection of meglumine antimoniate in the treatment of cutaneous leishmaniasis: a randomized controlled clinical trial. PLoS ONE, 8, e66123.
31.
BumbR.A., MehtaR.D., GhiyaB.C., JakharR., PrasadN., SoniP., Lezama-DavilaC., SatoskarA.R. (2010) Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous leishmaniasis in India. British Journal of Dermatology, 163, 854–858.
32.
de LimaS.C., TeixeiraM.J., LopesJ.E.Jr., de MoraisS.M., TorresA.F., BragaM.A., RodriguesR.O., SantiagoG.M., MartinsA.C., Nagao-DiasA.T. (2014) In vitro and in vivo leishmanicidal activity of Astronium fraxinifolium (Schott) and Plectranthus amboinicus (Lour.) Spreng against Leishmania (Viannia) braziliensis. BioMed Research International, 2014, 848293.
33.
FerreiraM.E., de AriasA.R., YaluffG., de BilbaoN.V., NakayamaH., TorresS., SchininiA., GuyI., HeinzenH., FournetA. (2010) Antileishmanial activity of furoquinolines and coumarins from Helietta apiculata. Phytomedicine, 17, 375–378.
34.
MonzoteL., PastorJ., ScullR., GilleL. (2014) Antileishmanial activity of essential oil from Chenopodium ambrosioides and its main components against experimental cutaneous leishmaniasis in BALB/c mice. Phytomedicine, 21, 1048–1052.
35.
(a) SouzaV.L., SouzaJ.A., SilvaT.M.C., VerasP.S.T., FreitasL.A.R. (2000) Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice. Microbes and Infection, 15, 1807–1815; (b) Aguiar MG, Machado AM, Fernandes AP, Miranda LA. (2010) Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis. Antimicrobial Agents and Chemotherapy, 54, 4699–4704.
36.
AdamsR.P. (2007) Identification of Essential Oil Components by Gas Chromatography / Mass Spectrometry, 4th Ed. Allured Publishing, Carol Stream, Illinois.
37.
BodleyA.L., McGarryM.W., ShapiroT.A. (1995) Drug cytotoxicity assay for African trypanosomes and Leishmania species. Journal of Infectious Diseases, 172, 1157–1159.
38.
CaioT.S.E., LimaM.D., KaplanM.A.C., NazarethM.M., Rossi-BergmannB. (1999) Selective effect of 2′,6′-dihydroxy-4′-methoxychalcone isolated from Piper aduncum on Leishmania amazonensis. Antimicrobial Agents and Chemotherapy, 43, 1234–1241.
39.
DelorenziM., AttiasC.R., Gattass. (2001) Antileishmanial activity of an indole alkaloid from Peschiera australis. Antimicrobial Agents and Chemotherapy, 45, 1349–1354.
40.
SladowskiD., SteerS.J., ClothierR.H., BallsM. (1993) An improved MTT assay. Journal of Immunological Methods, 157, 203–207.
41.
ShiojiT.T., Ueda-NakamuraT., GarciaD.C., PradoB.D., MorgadoJÁ, de SouzaW., NakamuraC.V. (2005) Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium. Antimicrobial Agents and Chemotherapy, 49, 176–182.
42.
BuffetP.A., SulahianA., GarinY.J.F., NassarN., DerouinF. (1995) Culture microtitration: A sensitive method for quantifying Leishmania infantum in tissues of infected mice. Antimicrobial Agents and Chemotherapy, 39, 2167–2168.
